Join us as we review recent practice-changing articles addressing the questions: Do weekend warriors experience a mortality benefit from exercise? Is an aggressive fluid strategy superior to a moderate strategy in acute pancreatitis? Does an invite for colonoscopy decrease colon cancer-related mortality? Did the benefits of intensive blood pressure control continue after the SPRINT trial ended? Fill your plate with a stack of hot tofurkey cakes! Featuring Drs. Era Kryzhanovskaya (@erakryzhmd), Nora Taranto (@norataranto), Paul Williams (@PaulNWilliamz), Rahul Ganatra (@rbganatra), and Matt Watto (@doctorwatto).
Claim free CME for this episode at curbsiders.vcuhealth.org!
Episodes | Subscribe | Spotify | Swag! | Mailing List | [email protected] | Free CME!
Show Segments
Credits
Visit betterhelp.com/curb to save 10% off your first month.
Sponsor: Birch Living
Go to birchliving.com/curb to get $400 off and 2 free eco-rest pillows.
Claim free CME for this episode at curbsiders.vcuhealth.org!
Episodes | Subscribe | Spotify | Swag! | Mailing List | [email protected] | Free CME!
Show Segments
- Intro, disclaimer
- Do weekend warriors experience a mortality benefit?
- Should you choose aggressive or moderate fluid resuscitation for acute pancreatitis?
- Does an invite for screening colonoscopy reduce colon cancer and CRC-related mortality?
- Did benefits from the SPRINT trial persist in observational follow up?
- Outro
Credits
- Written and Hosted by: Era Kryzhanovskaya, MD, Nora Taranto MD; Rahul Ganatra MD, MPH; Paul Williams, MD, FACP, Matthew Watto MD, FACP
- Cover Art: Matthew Watto MD, FACP
- Reviewer: Rahul Ganatral MD, MPH
- Technical Production: Pod Paste
Visit betterhelp.com/curb to save 10% off your first month.
Sponsor: Birch Living
Go to birchliving.com/curb to get $400 off and 2 free eco-rest pillows.
Fler avsnitt av The Curbsiders Internal Medicine Podcast
Visa alla avsnitt av The Curbsiders Internal Medicine PodcastThe Curbsiders Internal Medicine Podcast med The Curbsiders Internal Medicine Podcast finns tillgänglig på flera plattformar. Informationen på denna sida kommer från offentliga podd-flöden.
